Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)

Area of Science:

• Oncology
• Gastroenterology
• Clinical Medicine

Background:

• Colorectal cancer (CRC) exhibits distinct clinico-pathological features based on primary tumor location (right vs. left side).
• Tumor sidedness is increasingly recognized as a significant factor influencing prognosis and therapeutic response in CRC.
• Existing research highlights potential biological differences and differential responses to therapy correlating with tumor location.

Purpose of the Study:

• To comprehensively review the clinico-pathological characteristics of right-sided versus left-sided colorectal adenocarcinoma.
• To analyze the impact of primary tumor location (sidedness) on the overall prognosis of colorectal cancer.
• To discuss current clinical data on tumor sidedness specifically within the context of heavily pre-treated metastatic colorectal cancer (second and subsequent lines of therapy).

Main Methods:

• Systematic literature review of studies investigating clinico-pathological features of right and left colorectal cancer.
• Analysis of clinical data focusing on the prognostic implications of tumor sidedness in metastatic colorectal cancer.
• Specific focus on evaluating data related to tumor sidedness in patients undergoing second and subsequent lines of therapy for metastatic disease.

Main Results:

• Significant clinico-pathological differences exist between right and left colorectal adenocarcinomas, affecting patient outcomes.
• Primary tumor location demonstrates a notable impact on prognosis, particularly as colorectal cancer progresses.
• Limited but emerging data suggests differential treatment responses based on sidedness in metastatic settings, especially in heavily pre-treated populations.

Conclusions:

• Tumor sidedness is a critical factor in understanding colorectal cancer biology, prognosis, and treatment efficacy.
• The review addresses a gap in knowledge regarding the clinical implications of sidedness in advanced, heavily pre-treated metastatic colorectal cancer.
• Further research into sidedness-specific therapeutic strategies is warranted for improved patient outcomes in metastatic colorectal cancer.